Question 1

What is the catalog number for Aspulvinone O?

Accepted Answer

The catalog number for Aspulvinone O is A185-5MG.

Question 2

What sizes are available for Aspulvinone O?

Accepted Answer

Aspulvinone O is available in the following size(s): 5 mg.

Question 3

Is Aspulvinone O in stock?

Accepted Answer

Aspulvinone O is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Can this product be used for co-immunoprecipitation (Co-IP)?

Accepted Answer

Suitability for Co-IP depends on the specific antibody and is noted under validated applications on the datasheet. If it isn’t listed, contact our technical support team for guidance based on your target and sample type.

Question 5

Is this kit compatible with automated liquid handling platforms?

Accepted Answer

Automation compatibility varies by kit and isn’t always listed on the datasheet. Contact our technical support team with details of your platform so we can confirm with the manufacturer.

Question 6

What applications has this product been validated for?

Accepted Answer

Validated applications such as WB, ELISA, IHC, ICC, or FC are listed on the product datasheet. If you need application-specific validation data before ordering, contact our technical support team with the catalogue number.

Aspulvinone O

Product Specifications

CAS Number

Applications

Purity

Molecular Formula

Molecular Weight

Shipping Conditions

Storage Conditions

Frequently Asked Questions

Explore Other Products

FITC-Linked Polyclonal Antibody to Cat Eye Syndrome Chromosome Region, Candidate 1 (CECR1)

FITC-Linked Polyclonal Antibody to Cat Eye Syndrome Chromosome Region, Candidate 1 (CECR1)

FITC-Linked Polyclonal Antibody to Cat Eye Syndrome Chromosome Region, Candidate 1 (CECR1)

FITC-Linked Polyclonal Antibody to Cat Eye Syndrome Chromosome Region, Candidate 1 (CECR1)

FITC-Linked Polyclonal Antibody to Cat Eye Syndrome Chromosome Region, Candidate 1 (CECR1)

FITC-Linked Polyclonal Antibody to Cat Eye Syndrome Chromosome Region, Candidate 1 (CECR1)